Acrivon Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Name: Acrivon Therapeutics Inc: Is Infosys Ltd. worth buying?
Item: Acrivon Therapeutics Inc
Rating: 1.31600
Author: Trendlyne DVM scores

about

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient resp...

1.34 0.00 (0.00%)

86.60% Fall from 52W High

97,765

XNAS Volume

XNAS 03 Sep, 2025 5:30 PM (EDT)

Not Eligible

Expensive Valuation

16.0 / 100

Technically Neutral

36.6 / 100

No estimates available

Acrivon Therapeutics Inc Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Acrivon Therapeutics Inc Live Stock Price Today, Share Analysis and Chart

Acrivon Therapeutics Inc is a clinical-stage biopharmaceutical company developing oncology medicines that the Firm matches to patients whose tumors are predicted to be sensitive to each specific medicine by utilizing its proteomics-based patient resp...

86.60% Fall from 52W High

SWOT Analysis

Acrivon Therapeutics Inc Live Price Chart